Table 6.

Evaluation data of CL 14 subjected to a stability study; data are expressed as the mean value (n = 3).

Time (month)	% T	SET (second)	Mean droplet size (nm)	Zeta potential (mV)	Drug content (%)
0	99.85 ± 1.53	10.5 ± 0.92	19.30 ± 2.05	− 17.7 ± 2.19	100.42 ± 5.88
1	100.38 ± 0.82	11.53 ± 1.33	18.68 ± 0.588	− 16.5 ± 4.03	100.91 ± 2.47
2	100.62 ± 1.28	10.93 ± 1.7	17.46 ± 1.38	− 13.7 ± 5.64	99.46 ± 0.56
3	99.7 ± 0.93	10.77 ± 1.89	22.37 ± 0.979	− 17.3 ± 1.21	99.95 ± 1.41